System Transmission

Top Signal

100#1 JOB

Activity

2166Ripe

+922 today

System

Livenow

Terminal Asset View

stockNASDAQ

DMAC

$7.28+0.55%

DiaMedica Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

42Neutral

Live Analysis Active

Company Mission

DiaMedica Therapeutics is a biotechnology company that develops new medicines for serious medical conditions like kidney disease and stroke. They create these treatments through scientific research and clinical trials, then work to get them approved by regulatory agencies. The company makes money primarily through research grants and by partnering with larger pharmaceutical companies who help fund development and commercialization.

DMA

Industry Context

DiaMedica operates in the biotechnology sector, which focuses on developing new medical treatments. This industry is known for high research costs and long development timelines, with companies often spending years testing drugs before they can be sold. Success depends heavily on clinical trial results and regulatory approvals from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

55Matrix

Market Momentum

35.6— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

0.55%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing DMAC across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:24 PM UTC

As-of 03-15-2026 15:08 UTC

Develops new medicines for strokes and kidney disease, making money by selling successful drugs to pharmaceutical companies.

Price below key moving averages, suggesting a downtrend as sellers have been in control for an extended period showing consolidation pattern.

Biotech sector showing volatility as FDA approval timelines create uncertainty, watch for industry sentiment shifts affecting development-stage, suggesting affecting development-stage.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...